Vaxcyte, Inc. Common Stock (PCVX) News
Latest headlines that mention PCVX, newest first · each headline opens the original publisher
- Last price
- $65.02
- Day change
- -2.90%
- Next earnings
- 2026-11-03
PCVX headlines
last 30 daysBiotech stocks took a hit Tuesday, with Vaxcyte, Moderna and Revolution Medicines posting some of the steepest losses. The post Biotech Stocks Tumble, With Recent Winners Moderna, Vaxcyte Among The Biggest Losers appeared first on Investor's Business Daily .
Vaxcyte stock catapulted Monday after its experimental pneumococcal vaccine proved it's not inferior to marketed shots from Pfizer and Merck. The post Vaxcyte Catapults After Going Toe-To-Toe With Pfizer, Merck In Vaccine Study appeared first on Investor's Business Daily .
Also mentioned with PCVX
30dHeadlines that tag both tickers
PCVX news alerts
Get an alert by email or push when a new headline mentions PCVX.
More news
News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.